Ricerca Biosciences/Instem Collaboration Delivers Improved Quality in Drug Safety Studies
Ricerca Biosciences
is pleased to announce the successful result of a partnership with
Instem
, a leading provider of laboratory data and information management solutions. The collaboration resulted in the development of a novel approach to eliminating potential misdosing during drug safety studies.
With the goal of improving quality management processes for clients and ensuring the integrity of study data, the Ricerca team in Lyon, France, approached Instem and proposed an upgrade to their
Provantis
software suite, which would help eliminate dosage errors. The Ricerca team created the requirement specifications and Instem enhanced the latest version of Provantis, enabling it to automatically verify and control correct dosing before administration by using existing bar code technology. The enhanced functionality replaces manual controls, which are not completely reliable, and streamlines the drug dosing process, thereby eliminating the potential for errors.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025